iPAI-1 determines the activity of MT1-MMP–dependent HSPC migration. Percentages of migrated Lin⁻c-kit⁺ cells in in vitro (A) or in vivo (B) experiments (n = 6 each). rPAI-1, recombinant plasminogen activator inhibitor-1. Means ± SD are shown in each bar graph.